PLEURAMED
Live / Applied — Second extension granted (statement of use) (as of 01 Oct 2025)
What this means for you
Not registered yet, but its 30 Nov 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98293621
- Mark type
- Stylized text
- Filed
- 30 Nov 2023
- Published for opposition
- 06 Aug 2024
- Attorney of record
- Christopher D. Olszyk, Jr.
Goods and services
- Class 042 — Scientific and technological services: Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Scientific research for medical purposes in the field of cancerous diseases; Pharmaceutical research services; Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical drug development services; Clinical research in the fields of cancer treatments, prevention and surgical procedures
Owner
- TDL Innovations LLC, Princeton, NJ, US
- TDL Innovations LLC, Princeton, NJ, US
Prosecution history
- 02 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Oct 2025 — SOU EXTENSION 2 GRANTED
- 01 Oct 2025 — SOU EXTENSION 2 FILED
- 01 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Mar 2025 — SOU EXTENSION 1 GRANTED
- 28 Mar 2025 — SOU EXTENSION 1 FILED
- 28 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Oct 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Aug 2024 — PUBLISHED FOR OPPOSITION
- 17 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Jun 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Jun 2024 — ASSIGNED TO EXAMINER
- 24 Feb 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED